Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-03-03
4:30 pm
Sale
13DMarker Therapeutics, Inc.
MRKR
Aisling Capital IV LP464,285
5.46%
-3,035,715decrease
(-86.73%)
View
2021-03-26
10:38 am
Purchase
13DMarker Therapeutics, Inc.
MRKR
New Enterprise Associates 16 L.P.14,464,285
17.4%
14,464,285increase
(New Position)
View
2021-03-23
7:45 pm
Sale
13DMarker Therapeutics, Inc.
MRKR
Leen Ann M.2,415,842
2.89%
-300,000decrease
(-11.05%)
View
2021-03-15
4:45 pm
Sale
13DMarker Therapeutics, Inc.
MRKR
Eastern Capital LTD3,966,668
5%
-500,000decrease
(-11.19%)
View
2020-11-13
4:14 pm
Sale
13DMarker Therapeutics, Inc.
MRKR
Eastern Capital LTD4,466,668
9.2%
-416,667decrease
(-8.53%)
View
2020-06-18
4:42 pm
Sale
13DMarker Therapeutics, Inc.
MRKR
Eastern Capital LTD4,883,335
10.3%
-416,667decrease
(-7.86%)
View
2020-02-20
4:24 pm
Unchanged
13DMarker Therapeutics, Inc.
MRKR
Eastern Capital LTD5,300,002
11.2%
0
(Unchanged)
View
2020-02-14
4:27 pm
Sale
13GMarker Therapeutics, Inc.
MRKR
PERCEPTIVE ADVISORS LLC0
0%
-3,500,000decrease
(Position Closed)
View
2019-02-14
4:36 pm
Purchase
13GMarker Therapeutics, Inc.
MRKR
PERCEPTIVE ADVISORS LLC3,500,000
7.5%
3,500,000increase
(New Position)
View
2019-02-14
11:21 am
Purchase
13DMarker Therapeutics, Inc.
MRKR
Vera Juan2,715,842
5.9%
2,715,842increase
(New Position)
View
2019-02-14
11:19 am
Purchase
13DMarker Therapeutics, Inc.
MRKR
Leen Ann M.2,715,842
5.9%
2,715,842increase
(New Position)
View
2019-02-14
11:15 am
Purchase
13DMarker Therapeutics, Inc.
MRKR
Wilson John Robert8,261,853
17.37%
8,261,853increase
(New Position)
View
2019-02-04
09:29 am
Sale
13GMarker Therapeutics, Inc.
MRKR
Brio Capital Master Fund Ltd.237,496
0.05%
-560,548decrease
(-70.24%)
View
2018-11-08
11:22 am
Unchanged
13DMarker Therapeutics, Inc.
MRKR
Eastern Capital LTD5,300,002
11.3%
0
(Unchanged)
View
2018-10-25
4:13 pm
Purchase
13DMarker Therapeutics, Inc.
MRKR
New Enterprise Associates 16 L.P.8,750,000
17.8%
8,750,000increase
(New Position)
View
2018-10-19
5:09 pm
Purchase
13DMarker Therapeutics, Inc.
MRKR
Aisling Capital IV LP3,500,000
7.7%
3,500,000increase
(New Position)
View